Current Research in Structural Biology, published by Elsevier, is a pioneering Open Access journal that has rapidly gained prominence since its inception in 2019. With a focus on advancing the understanding of molecular and structural biology, this journal provides a platform for researchers and professionals to publish groundbreaking findings that contribute to the field's ongoing development. With a commendable Q2 ranking in both Molecular Biology and Structural Biology categories for 2023, it serves as a vital resource for the community, ensuring accessibility to high-quality research. The journal is indexed in Scopus, showcasing its significant impact and relevance, particularly with a ranking of #26/49 in the Structural Biology discipline. Located in the heart of the Netherlands, Current Research in Structural Biology not only fosters academic discourse but also encourages collaborative research efforts in addressing critical biological questions. Whether you are a researcher, student, or industry professional, this journal is essential for staying abreast of the latest advancements and trends in structural biology.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, published by Taylor & Francis Ltd, is a premier open-access journal that has been at the forefront of research in the field of medicinal chemistry since its inception in 1985. With an ISSN of 1475-6366 and an E-ISSN of 1475-6374, this journal boasts a prestigious reputation reflected in its impressive Q1 rankings across critical categories such as Drug Discovery and Pharmacology as of 2023. Situated in the United Kingdom, it plays a vital role in disseminating high-quality research that addresses the burgeoning needs of drug discovery and enzyme inhibition methodologies. The journal supports full open access, providing a platform for researchers, professionals, and students to share significant findings and innovations widely. With a robust impact factor, the JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY is indispensable for any academic or professional involved in the pharmacological sciences, offering an unparalleled insight into the latest advancements in therapeutic strategies and drug development.

CELL BIOCHEMISTRY AND BIOPHYSICS is a distinguished journal published by HUMANA PRESS INC, focusing on critical advancements in the fields of biochemistry, biophysics, and cell biology. Since its establishment, the journal has provided a robust platform for the dissemination of cutting-edge research, covering diverse aspects of cellular biochemistry and the physical principles that underlie biological systems. With an emphasis on interdisciplinary studies, the journal aims to facilitate knowledge exchange among researchers, professionals, and students from various scientific backgrounds. As reflected in its 2023 category rankings, it holds a respectable position in Q3 for Biochemistry and Cell Biology, and Q2 for both Biophysics and Medicine (miscellaneous), indicating its significant contribution to these fields. Although it operates under a subscription model, the journal's commitment to maintaining high publication standards ensures that only impactful studies are shared with its audience. With a range of articles spanning theoretical insights to practical applications, CELL BIOCHEMISTRY AND BIOPHYSICS is an essential resource for those aiming to stay at the forefront of biochemical and biophysical research.

Letters in Drug Design & Discovery is an esteemed journal dedicated to advancing the fields of Drug Discovery and Molecular Medicine. Published by Bentham Science Publishers, this journal offers a platform for the dissemination of innovative research and advanced methodologies, enhancing collaboration among researchers and professionals in pharmaceutical sciences. Despite its current Q4 ranking in Drug Discovery and Molecular Medicine and Q3 in Pharmaceutical Science for 2023, the journal is committed to improving its presence in the academic community by providing quality, peer-reviewed publications that cover various aspects of drug design and discovery, including novel therapeutic approaches and methodologies. With a focus on both foundational and cutting-edge research from around the globe, Letters in Drug Design & Discovery is pivotal for those seeking to stay abreast of developments in drug development and molecular research. Researchers are encouraged to submit their work, engage with the burgeoning field, and contribute to the ongoing dialogue driven by this journal, which spans the years from 2005 to 2024. While the journal does not currently offer open access, its contributions remain accessible to a wide range of academic and professional audiences.

INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS is a well-regarded academic journal that serves as a vital platform for researchers in the fields of biochemistry and biophysics. Published by the NATL INST SCIENCE COMMUNICATION-NISCAIR since its inception in 1972, this Open Access journal has committed itself to disseminating high-quality research and advancements in these dynamic fields, allowing readers worldwide to access vital findings since 2009. The journal maintains a robust presence in the academic landscape, achieving noteworthy rankings in 2023, placing it in the Q4 category for Biochemistry and Q3 for both Biophysics and miscellaneous Medicine, alongside its respectable Scopus rankings. With an emphasis on original research articles, reviews, and educational contributions, the INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS plays an essential role in fostering scientific dialogue and collaboration among professionals and students alike. For scholars seeking to stay at the forefront of biochemistry and biophysics research, this journal is an indispensable resource that fosters knowledge exchange and elevates the field on both a national and international scale.

BIOCHEMISTRY is a premier academic journal published by the American Chemical Society, dedicated to advancing the field of biochemistry through the dissemination of high-quality research. With an ISSN of 0006-2960 and an e-ISSN of 1520-4995, this esteemed publication has been a vital resource since its inception in 1962 and continues to contribute to the scientific community, boasting a remarkable Q1 ranking in the field as of 2023. The journal's well-curated content emphasizes fundamental biochemical research, molecular genetics, and innovations in biochemical techniques, catering to a diverse audience of researchers, professionals, and students. Although not an open-access publication, BIOCHEMISTRY plays a crucial role in facilitating knowledge exchange and fostering academic collaboration globally, making significant contributions to the understanding of the biochemical processes that underpin life.

Molecular Informatics is a prestigious journal published by WILEY-V C H VERLAG GMBH, dedicated to advancing the fields of computational analysis and molecular modeling. As a key resource in the realms of Computer Science Applications, Drug Discovery, Molecular Medicine, Organic Chemistry, and Structural Biology, this journal is recognized for its significant contributions and is ranked in the Q2 and Q3 categories across multiple disciplines, positioning it among the leading journals for researchers and academics. With an impressive track record since its inception in 2010 and converging its contributions until 2024, Molecular Informatics aims to bridge the gap between computational techniques and biological applications, promoting interdisciplinary collaboration and innovation. Accessible to a global audience, the journal reflects a commitment to advancing science through open access options, making cutting-edge research available to students, professionals, and decision-makers alike. This journal serves as an indispensable platform for disseminating high-quality research and fostering the development of new theoretical and practical frameworks in molecular informatics.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, published by TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing our understanding of receptor biology and signal transduction mechanisms. With an ISSN of 1079-9893 and an E-ISSN of 1532-4281, this journal has maintained a reputable standing since its inception in 1980, continually addressing pivotal topics in biochemistry, cell biology, and molecular biology. As evidenced by its 2023 Scopus rankings, which place it in the 64th percentile for Biochemistry and Genetics and Molecular Biology, JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION remains a vital source for cutting-edge research, providing insights that are essential for both academic and practical applications. Although the journal currently offers limited open access options, it stands out in the Q2 and Q3 quartiles of its respective categories, making it an invaluable resource for researchers, professionals, and students aiming to stay abreast of the latest findings and methodologies in receptor and signaling research. The journal's commitment to disseminating high-quality research underscores its significance within the scientific community, fostering innovation and collaboration across disciplines.

PROTEIN SCIENCE, published by Wiley, is a premier journal dedicated to the field of biochemistry, molecular biology, and medicine, boasting an impressive impact factor that reflects its influence and importance within the academic community. Established in 1992, the journal has continuously provided a platform for high-quality research, with a current classification in the top quartile (Q1) for its critical contributions to the understanding of protein structure and function, as well as its applications in health and disease. With a Scopus ranking placing it in the 91st percentile among its peers, PROTEIN SCIENCE publishes cutting-edge studies and reviews that are essential for researchers, professionals, and students seeking to advance their knowledge in protein research. Although it does not currently offer open access options, the journal remains dedicated to disseminating vital findings that support the ongoing advancements in molecular biology and biochemistry. Researchers can count on PROTEIN SCIENCE for consistently rigorous peer-reviewed content that fosters meaningful dialog and innovation in the life sciences.

Chemical Biology Letters is a prominent academic journal dedicated to the evolving field of biochemistry and its applications in medical and clinical contexts. Published by ScienceIn Publications, this journal serves as a vital platform for researchers, professionals, and students alike, showcasing cutting-edge findings and innovations that drive forward our understanding of chemical interactions in biological systems. With its scope ranging from molecular biology to clinical biochemistry, Chemical Biology Letters is committed to advancing knowledge and fostering collaboration within the scientific community. Recognized for its quality, the journal is categorized in Q4 for Biochemistry and Molecular Biology fields, while achieving notably higher ranks in Medical Biochemistry, reflecting its significant contributions to the discipline. Aiming to remain accessible to a diverse audience, the journal is published in open access format, inviting researchers worldwide to explore and share invaluable insights. Established in 2014, it continues to grow in impact and relevance, paving the way for advancements in both theoretical and applied research within the realm of chemical biology.